4//SEC Filing
Salvadori Daniel Gesua Sive 4
Accession 0001415889-21-006263
CIK 0000001800other
Filed
Dec 27, 7:00 PM ET
Accepted
Dec 28, 5:20 PM ET
Size
12.1 KB
Accession
0001415889-21-006263
Insider Transaction Report
Form 4
Salvadori Daniel Gesua Sive
Senior Vice President
Transactions
- Exercise/Conversion
Option (right to buy)
2021-12-23−23,771→ 23,771 totalExercise: $38.40From: 2018-02-19Exp: 2026-02-18→ Common Shares (23,771 underlying) - Exercise/Conversion
Common shares without par value
2021-12-23$38.40/sh+23,771$912,806→ 127,702 total - Exercise/Conversion
Common shares without par value
2021-12-23$44.40/sh+31,229$1,386,568→ 158,931 total - Sale
Common shares without par value
2021-12-23$140.00/sh−58,501$8,190,140→ 100,430 total - Exercise/Conversion
Option (right to buy)
2021-12-23−31,229→ 75,591 totalExercise: $44.40From: 2019-02-17Exp: 2027-02-16→ Common Shares (31,229 underlying)
Footnotes (1)
- [F1]Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.
Documents
Issuer
ABBOTT LABORATORIES
CIK 0000001800
Entity typeother
Related Parties
1- filerCIK 0001620564
Filing Metadata
- Form type
- 4
- Filed
- Dec 27, 7:00 PM ET
- Accepted
- Dec 28, 5:20 PM ET
- Size
- 12.1 KB